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Abstract
Background: The production of stable and soluble proteins is one of the most important steps prior to structural and 
functional studies of biological importance. We investigated the parallel production in a medium throughput strategy 
of genes coding for proteins from various marine organisms, using protocols that involved recombinatorial cloning, 
protein expression screening and batch purification. This strategy was applied in order to respond to the need for post-
genomic validation of the recent success of a large number of marine genomic projects. Indeed, the upcoming 
challenge is to go beyond the bioinformatic data, since the bias introduced through the genomes of the so called 
model organisms leads to numerous proteins of unknown function in the still unexplored world of the oceanic 
organisms.
Results: We present here the results of expression tests for 192 targets using a 96-well plate format. Genes were PCR 
amplified and cloned in parallel into expression vectors pFO4 and pGEX-4T-1, in order to express proteins N-terminally 
fused to a six-histidine-tag and to a GST-tag, respectively. Small-scale expression and purification permitted isolation of 
84 soluble proteins and 34 insoluble proteins, which could also be used in refolding assays. Selected examples of 
proteins expressed and purified to a larger scale are presented.
Conclusions: The objective of this program was to get around the bottlenecks of soluble, active protein expression 
and crystallization for post-genomic validation of a number of proteins that come from various marine organisms. 
Multiplying the constructions, vectors and targets treated in parallel is important for the success of a medium 
throughput strategy and considerably increases the chances to get rapid access to pure and soluble protein samples, 
needed for the subsequent biochemical characterizations. Our set up of a medium throughput strategy applied to 
genes from marine organisms had a mean success rate of 44% soluble protein expression from marine bacteria, 
archaea as well as eukaryotic organisms. This success rate compares favorably with other protein screening projects, 
particularly for eukaryotic proteins. Several purified targets have already formed the base for experiments aimed at 
post-genomic validation.
Background
The marine environment is highly complex and contains
the vast majority of known and unknown biodiversity. It
is also the last frontier to understand the control of the
global climate and hides a wealth of biological resources
still to be tapped for food, health and energy. Up until
very recently, few genomic data were available for oceanic
organisms, but this panorama is rapidly changing with a
number of genomic projects now underway, which focus
on marine organisms, ranging from microbes [1,2] to
multicellular eukaryotes including vertebrates or macro-
algae [3], as well as the generation of resources and access
to genomes or EST libraries for various eukaryotic sys-
tems [4-7]. The wealth of sequence data arising from
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these projects, means that researchers are confronted
with a huge number of putative genes, the function of
which are, at best, so far only deduced from sequence
comparisons (automatic annotation). The pressing ques-
tion is how to analyze the genomic data with respect to
original biological processes in diverse marine organisms
(i.e. their development or stress response), their impor-
tance in adaptation to the particular habitat and how to
identify new enzymes and/or metabolites of biotechno-
logical interest. Thus, the availability of complete genome
data has resulted in the development of transcriptomic
and proteomic methods that can be used to study regula-
tory networks and interactions of thousands of genes in
parallel, allowing an efficient global analysis of genomic
information. However, there are a number of clear draw-
backs with these methods in so far that they are strongly
dependent on the quality of the genome annotation,
which at present assumes conserved functions across
often widely distant taxa. Furthermore, these techniques
give at most only an indication of the regulation/meta-
bolic pathway the corresponding gene product belongs
to, and little or no information on the precise biochemical
function of unknown genes.
To understand the precise biological function of a sin-
gle gene, the biochemical and physiological characteriza-
tion of its product is essential and this is often greatly
aided by the availability of 3-D structural information.
Although the 3D structure does not always reveal the nat-
ural substrate, it has been shown repeatedly that it helps
at least find the class of compounds among which the
substrate will be found [8,9]. Several bottlenecks exist in
the analysis of individual proteins; generally the tech-
niques utilized require systems for the efficient over-
expression of the target gene in order to produce suffi-
cient recombinant protein. Furthermore, to constitute an
assessment for potential biotechnological applications of
the discovered proteins/enzymes, the effective recombi-
nant expression of biologically active proteins is essential.
When aiming at the 3D-structure of the protein of inter-
est, a second bottleneck is encountered at the step of
crystallization of these proteins. Recent developments in
the field of structural genomics have demonstrated that
medium/high throughput strategies are most adapted to
the production of large numbers of soluble and active
gene products and/or protein crystals at a time [10,11],
since they allow simultaneous testing of numerous condi-
tions with an optimized effort.
In this study, our objective was to set up and apply a
medium throughput strategy for the production, expres-
sion and, at least for some candidates, the crystallization
of selected proteins from marine organisms. With this
approach, we targeted proteins from various marine
organisms including archaea, bacteria and eukaryotes but
also proteins from different families of interest as for
example enzymes involved in the metabolism of carbohy-
drates, stress related proteins or cellular division proteins
(Table 1). On the basis of its ease of genetic manipulation,
its rapid growth rate, low cost and robustness Escherichia
coli still remains the most popular expression system [12].
Moreover, the results of high-throughput programs (such
as those funded under the NIH Protein structure Initia-
tive (PSI) [13] available on the site PSI/targetDB http://
targetdb.pdb.org/ show that in term of full-length pro-
teins, up to 50% of proteins from the Eubacteria or
Archaea and 10% of proteins from Eukarya can be
expressed in E. coli in soluble form [14]. We have there-
Table 1: Availability of genomic data to the Marine Express partners.
Organism Taxonomy Gene families of interest State of genomic data Partner
Pyrococcus abyssi Euryarchaeota Proteins from the DNA replication 
system
Genome published [1] IFREMER
Brest, France
Zobellia galactanivorans Flavobacteria Polysacchride metabolism, sulfatases Genome complete SBR Roscoff, France
Ectocarpus siliculosus Brown alga Stress related genes, carbohydrate 
active enzymes
14000 ESTs, Genome 
complete
SBR Roscoff, France
Ostreococcus tauri Green microalga Biological clock Genome published [4] Arago Banyuls, France
Ciona intestinalis Urochordate Hox-genes, Ci-msx, Ci-RX Genome published [5] SZ A. Dohrn, Napoli, Italia
Sparus aurata Teleost fish Hormones, calcium and musculo-
skeletal development, stress related
30000 ESTs and 20 full 
length cDNAs
CCMAR Faro, Protugal
Archaeal virus (PAV1) Not yet classified Any Genome published [28] UBO, LM2E, Brest, FranceGroisillier et al. Microbial Cell Factories 2010, 9:45
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fore chosen this expression system for our purpose and
report the results of the parallel expression strategy in E.
coli  192 targeted genes, in two compatible expression
vectors, using a 96-well plate format. A selection of indi-
vidual targets that were successfully overexpressed in this
program, were subsequently further characterized in
order to determine their functional partners, cellular
localization, 3D structure and/or biochemical activity. As
a conclusion, three selected examples of these studies are
briefly discussed.
Results
Selection and bioinformatics analysis of the target genes
A subset of 200 target genes was selected by the different
partners involved in the program to evaluate the potential
for heterologous expression of marine organism genes in
E. coli. The gene families of interest, defined by the part-
ners and organized according to the organism of origin
and from three domains of life, are shown in Table 2. The
sequences of the genes and their corresponding predicted
proteins were analyzed by bioinformatic tools to assess
their suitability for expression in our bacterial medium
throughput strategy. The nucleotide-sequences were
screened for the absence of the selected restriction sites
for the gene cloning strategy. Where possible, the poten-
tial signal peptides and transmembrane domains were
removed in order to express soluble proteins. These were
therefore identified using SignalP and TMHMM servers,
respectively [15,16]. Another important feature that was
analyzed in this step was the protein modularity. It is
often assumed that single domains of proteins contain
important biological functions and are more likely to be
successfully expressed than the large, multi-modular pro-
teins. Moreover, the modularity of a protein is usually an
obstacle to its crystallization. Consequently, targeted pro-
teins were, where possible, cloned as full length proteins,
but also in the form of their individual modules. The
modular architecture of each target was examined using
Blast queries against UniProt database, as well as domain
searches with the InterPro server [17]. The crucial
choices of the N- and C-terminal boundaries of each
module were refined using Hydrophobic Cluster Analysis
(HCA) [18]. From 200 starting sequences, eighteen were
eliminated after restriction site analysis and eight because
of the presence of transmembrane zones throughout the
protein sequences.. Finally, 192 sequences encoding pro-
teins ranging from 7 to 140 kDa were analyzed and classi-
fied according to different restriction site strategies as
follows:  BamHI/EcoRI,  BamHI/MfeI,  BglII/EcoRI and
BglII/MfeI.
Amplification and cloning of DNA fragments
To optimize the amplification steps through PCR, spe-
cific primers were designed which had the same theoreti-
cal Tm value for all targets.
The starting genetic material was genomic DNA for
prokaryotes and full length cDNA for eukaryotic organ-
isms. Therefore, in parallel to the bioinformatic analysis,
an important step for eukaryotic proteins was to retrieve
full length cDNAs from the genetic material. This step
was performed separately by each partner by 5'RACE
PCR on available cDNA libraries. Selected target genes
were amplified by PCR using a general set of gene-spe-
cific primers (cf Methods). Even non-amplified targets
were included in subsequent steps and permitted recov-
ery of two genes in the cloning step. Overall, 183 out of
192 PCR fragments were obtained (Figure 1). These
recovered, non-amplified genes corresponded to cDNA
(obtained in weak concentration) or genomic DNA with a
size greater than 3500 base pairs.
In the present study, two expression vectors were used
to test recombinant protein expression and solubility.
Table 2: Comparison of obtained results covering three domains of living organisms
Eukarya Bacteria Archaea Total
pFO4 pGEX pFO4 pGEX pFO4 pGEX pFO4 pGEX combinedc
number of soluble proteins 14 13 13 25 18 26 45 64 84
number of insoluble proteins 10 19 4 5 12 24 26 48 34
no expressiona 42 37 11 2 31 11 84 50 52
no cloneb 85 4 0 9 1 2 3 7 3 0 2 2
percentage of soluble proteins 7% 7% 7% 13% 9% 14% 23% 33% 44%
percentage of soluble + insoluble proteins 13,00% 17% 9% 16% 16% 26% 37% 58% 61%
a number of targets for which no expected bands were visualized on SDS-PAGE gels
b number of target genes did not clone in expression vectors
c number of different soluble proteins obtained in pGEX or in pFO4 vectorsGroisillier et al. Microbial Cell Factories 2010, 9:45
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One vector (pFO4) contains a His6-tag at the N-terminal
for affinity purification; the second (pGEX-4T-1) allows
the production of a fusion protein with an N-terminal
glutathion-S-transferase (GST). This parallel PCR clon-
ing procedure could easily be performed in 96-well for-
m a t .  T h e  a p p r o a c h  r e l i e s  o n  t h e  u s e  o f  a  s i n g l e  P C R
product for each gene that is compatible for ligation to
both the expression vectors, pGEX-4T-1 and pFO4. Since
the expression vectors were digested with BamHI and
EcoRI, the upstream and downstream PCR primers intro-
duced BamHI (or its isocaudomer BglII) and EcoRI (or its
isocaudomer  MfeI) restriction sites, respectively, upon
PCR amplification. After transformation in E. coli DH5α
strains, the plasmids were validated by PCR screening of
colonies using primers specific for the expression vectors
and flanking the cloning sites. In this way, we obtained
174 cloned target genes (Figure 1). The efficiency for
direct cloning of these target genes from PCR products
was 95% (174 out of 183).
Expression and purification of recombinant proteins in 
small-scale experiments
The validated plasmids were used to transform appropri-
ate E. coli expression strains (Table 3). Fusion proteins in
pFO4 vector are under-control of a T7 promoter and in E.
coli cells containing a chromosomally located defective
prophage DE3 must be used for transformation. For Sev-
enty-seven genes that were cloned from archaea Rosetta
or Rosetta (DE3) strains were transformed, which com-
pensate for a number of rare codons in E. coli. For cloned
genes that contain several cysteines in their sequences
Origami or Origami (DE3) strains (14 genes) were trans-
formed. Indeed, these cells carry mutations for both the
thioredoxin reductase (trxB) and glutathione reductase
(gor) genes, mutations which greatly enhance disulfide
bond formation in the cytoplasm. For all other recombi-
nant vectors BL21 or BL21 (DE3) strains were used to be
transformed.
For 167 out of 183 cloned constructs that contained
inserts of the expected size small-scale experiments for
soluble protein expression were screened. A key step in
the automation of the small-scale experimental setup is
the development of auto-induction media (ZYP5052
medium used in the present study), which contain differ-
entially metabolized carbon sources that promote growth
to relatively high cell densities and then auto-induce by
the utilization of lactose. These media remove the need to
monitor cell densities or to add an inducer such as IPTG
in T7-based expression systems [19]. To further optimize
soluble protein expression, we used a culture temperature
of 20°C for 3 days, since it has been established by the
Structural Proteomics In Europe consortium [20] and oth-
ers that lower temperatures tend to be more effective
[21]. Moreover, in the present study 24-well plates instead
of the usual 96-well plates [14] were used to obtain better
aeration of the cells [22]. The final OD600 values that were
reached in the small-scale cultivation vessels ranged
between 10 and 16.
The expression and the solubility of the recombinant
proteins were tested by SDS-PAGE. Only for few target
clones it was possible to visually detect the protein band
corresponding to the fusion protein directly on SDS-
PAGE gels, as illustrated for some examples in Figure 2a.
Consequently, to validate the exact number of clones that
expressed proteins in the soluble fractions, we used
Microspin GST/HIS mini-columns (GE Healthcare Life
Science, USA) to perform a mini-purification screen.
Indeed, these mini-columns are used to purify a GST
fusion protein or a HIS fusion protein by affinity chroma-
tography. After incubation and washing, bound His-
tagged or GST-tagged proteins were eluted with elution
buffer containing imidazole or reducing-glutathion,
respectively. The elution results were again analyzed on
SDS-PAGE gels (Figure 2b). This evaluation method was
much more sensitive and revealed that 118 proteins out
of the 174 constructs (68%) were expressed, while 84 of
these 118 (71%) were found to be soluble (Table 2 and
Additional file 1, Table S1).
Scale-up expression and purification of targets from 
Pyrococcus abyssi
A relative high success rate (45% of solubly expressed tar-
gets) was obtained for targets originating from the hyper-
thermophilic archae Pyrococcus abyssi. A total of 37 out
of 77 expressed proteins were expressed soluble and eas-
ily purified in the small scale set up. To pursue the bio-
chemical characterization of these proteins, to date the
purification of 33 proteins has been performed at a larger
scale. The up-scaling was performed using culture vol-
umes of 200 ml and based on the protocols of the
medium throughput strategy. Independent of size or pro-
tein family, reasonable yields in the range of several mg of
Figure 1 Comparison of protein expression screening success. 
The percentage of success for each step in the protein production 
pipeline is shown. The number of targets represented at each stage is 
written above the bars.
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pure protein were obtained for the scaled-up targets, as
exemplified by four targets in Figure 3a. One of the aims
of the follow-up study based on the genome data of P.
abyssi is to identify novel partners in the archaeal DNA
repair/replication system. The purified and tagged pro-
teins are therefore subsequently used in pull-down/MS
experiments as previously described [23]. One example of
a successful pull-down experiment is illustrated in Figure
3b. The up-scaled, produced and purified target 92
(PAb0164, see Additional file 1, Table S1) was immobi-
lized on the column. Interacting proteins were co-puri-
fied and subsequently identified using an Ultraflex
MALDI-TOF/TOF instrument (Bruker Daltonics).
Up-scale, purification and crystallization of R-Z3597 from 
Zobellia galactanivorans
The genome of Z. galactanivorans contains approxi-
mately 50% of 'hypothetical proteins', as identified by bio-
informatic analysis (Barbeyron et al., in preparation). A
selection of these proteins, chosen because of very distant
similarity to glycoside hydrolases or because they were
collinear and found in close genomic context to other gly-
coside hydrolases, were targets for the heterologous
expression, to produce sufficient pure protein samples for
a complete structural and biochemical characterization.
In particular, R-Z3597 (target 43, Additional file 1, Table
S1) was successfully over expressed in soluble form and in
high yield. The scale-up of expression was performed
using the protocol established in the medium throughput
trial, but for 500 ml culture medium. The final yield after
two steps of purification (Nickel affinity and size exclu-
sion) was 15 mg (Figure 4a). A solubility screen, following
the strategy of Collins et al. [24] indicated that the best
results were obtained with a buffer composed of 50 mM
CHES pH 9.5, 500 mM NaCl and 100 mM imidazole. The
protein was concentrated in this buffer to a final concen-
tration of 12 mg/ml. Crystallisation conditions were
screened using three different commercial kits (PEGI,
PACT and JCSG+). Orthorhombic single crystals grew in
the optimized condition, containing 20% (w/v) PEG 3350
and 200 mM calcium acetate, within one or two weeks at
292 K (Figure 4b). The further biochemical characteriza-
tion, especially the screening for activity on various
marine oligo- and polysaccharides is currently in prog-
ress.
Scale-up, purification and crystallization of Staniocalcin1A 
from Sparus aurata
Functional characterization of proteins from Sparus
aurata involved in handling and regulation of calcium:
several categories of fish cDNA were provided to the flag-
ship project MARINE-EXPRESS and included hormones,
hormone responsive transcription factors, chaperones
and matrix proteins involved in hormone driven calcium
turnover. Target constructs used for further studies
included sea bream and Tetraodon nigroviridis Stannio-
calcins. In particular the expression of stanniocalcin1
(STCA1) from Tetraodon nigroviridis was scaled-up fol-
lowing the protocol established in the medium through-
put trial, but for 500 ml ZYP5052 culture medium. The
final yield after two steps of purification (Nickel affinity
and size exclusion) was about 12 mg (Figure 5a).
Crystallisation conditions were screened using three
variants of commercial kits (PEGI, PACT and JCSG+).
First thin, plate-like crystals grew in the condition, con-
taining PEG 4000 25% 0.1 M di-sodium citrate pH 5.6 and
0.2 M ammonium sulphate, within one or two weeks at
292 K (Figure 5b). The further biochemical characteriza-
tion and optimization of crystallization conditions to
produce crystals suitable for X-ray analysis is currently
under progress.
Figure 2 Assessing soluble and insoluble protein expression lev-
els in the medium throughput strategy. a. SDS-PAGE of Insoluble (I) 
and soluble (S) crude cellular extracts of the E. coli expression cultures. 
Targets 50 to 60 are shown. Black circles surround bands of correct size 
for a given target. b. Western-blot using anti-His antibody of selected 
targets highlighted after purification of soluble cell lysis extracts on 
mini-affinity (His) columns. Selected targets between 156 and 181 are 
shown. Pink circles highlight bands of correct size for a given target.Groisillier et al. Microbial Cell Factories 2010, 9:45
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Discussion
Based on sequence analysis, a large proportion of genes
from genomic data of marine organisms have unknown
cellular and/or molecular functions. One major challenge
is to assign biological function and to elucidate the mech-
anism of action of such genes. This challenge involves
techniques to elucidate the structure and function of the
gene products, interactions between proteins and/or
global protein changes. For example, the three-dimen-
sional structure of a protein can often provide functional
clues, primarily by detecting structural similarity with a
protein of known function even when sequence identity
is low [9]. Purified protein is generally required in these
Figure 3 Up-scale and purification of targets from P. abyssi. a. SDS-PAGE gel of up-scaled and purified HIS-tagged targets F75, F124, F127 and 
F167 before and after final polishing on Co2+ specific beads (SN = Supernatant of cell culture; B = after incubation with Dynabeads TALON; M = protein 
markers; F75 = test line; NI = F75 without induction). b. 12% SDS-PAGE analysis of a P. abyssi RadA (PAB0164, target 92 round R1) pull-down experiment. 
Proteins identified using an Ultraflex MALDI-TOF/TOF instrument (Bruker Daltonics) are indicated with arrows.
Figure 4 Up-scale purification and crystallization of R-Z3597 
from Zobellia galactanivorans. a. SDS-PAGE gel of up-scaled and pu-
rified His-tagged target Zg3597. Lane 1, soluble extract; lane 2, purified 
R-Z3597 by affinity chromatography using a Ni2+-charged resin; lane 3, 
R-Z3597 purified by size exclusion gel chromatography; M, standard 
molecular weight markers. b. Orthorhombic crystals of Zg3597 (0.1 × 
0.1 × 0.5 μm3)
Figure 5 Up-scale purification and crystallization of Stanniocal-
cin 1 of Sparus aurata. a. SDS-PAGE gel of up-scaled and purified His-
tagged target STCA1. b. First plate-like crystals of STCA1 (approximate 
size of 0.05 × 0.05 × 0.008 μm3).Groisillier et al. Microbial Cell Factories 2010, 9:45
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studies and is at the basis of the development of medium/
high throughput strategies to produce a large number of
soluble proteins [10,11]. A key feature to the success of
medium/high throughput cloning strategies is the opti-
mization of an identical treatment of all targets. More-
over, multiplying constructs, vectors and targets
consequently increase the chances to obtain pure, soluble
protein samples to pursue biochemical analyses. This has
also been demonstrated more recently by other expres-
sion systems, such as the ligation-independent cloning
(LIC) method of Mycobacterium tuberculosis gene
sequences [25].
The increased number of genomic projects concerning
marine organisms that are available, including prokary-
otic organisms [1,2] or eukaryotic organisms [3-7], as well
as projects still in progress (Ectocarpus siliculosus, Zobel-
lia galactanivorans), require the application of medium/
high throughput transcriptomic and proteomic methods.
Here, we show that a general scheme for bacterial
expression of genes originating from marine organisms
could be successfully implemented for the production of
soluble proteins. Relatively few studies have been per-
formed to assess medium/high throughput expression of
soluble proteins from marine organisms. However, in
general efforts have been concentrated on individual
organisms. For an example, the Southeast Collaboratory
for Structural Genomics has developed high throughput
protein production and crystallization of genes originat-
ing from Pyrococcus furiosus [26]. More recently, a series
of diatom expression vectors based on the Invitrogen
Gateway technology for high throughput protein tagging
and overexpression in Phaeodactylum tricornutum has
been described [27].
In the present study a medium throughput approach
was applied for the heterologous protein expression of
diverse marine organisms (including prokaryotes, archae
and eukaryotes) in the same system (Figure 6). This is in
contrast with previous studies that generally focus on one
organism of origin. The general concept of the MARINE-
EXPRESS program can be divided into three main parts:
i) the bioinformatics analysis of the target genes selected
by different partners, ii) the cloning of targeted genes into
Figure 6 Comparison of soluble and insoluble protein expression 
percentage in the three-domain system. Global comparison of the 
successful expression obtained from archaea, bacteria and eukarya. Eu-
karya are represented by the blue bars, Bacteria are represented by the 
red bars and Archaea are represented by the yellow bars.
0
10
20
30
40
50
60
70
80
% soluble proteins % insoluble
proteins
% soluble +
insoluble proteins
Eucarya
Bacteria
Archae
 
Table 3: Escherichia coli strains and plasmids used in this study.
Genotypes and relevant properties Sources or references
Strains
DH5α F- endA1 glnV44 thi-1 recA1 relA1 gyrA96 deoR nupG ϕ80dlacZΔM15 Δ(lacZYA-argF)U169, hsdR17
(rK- mK+), λ-
Promega, USA
BL21 F- ompT gal dcm lon hsdSB(rB
- mB
-) Novagen, USA
BL21 (DE3) F- ompT gal dcm lon hsdSB(rB
- mB
-) λ(DE3 [lacI lacUV5-T7 gene 1 ind1 sam7 nin5]) Novagen, USA
Rosetta F- ompT hsdSB(RB
- mB
-) gal dcm Novagen, USA
Rosetta 
(DE3)
F- ompT hsdSB(RB
- mB
-) gal dcm λ(DE3 [lacI lacUV5-T7 gene 1 ind1 sam7 nin5]) Novagen, USA
Origami F- ompT hsdSB rB
- mB
-) gal dcm lacY1 ahpC gor522::Tn10 (TcR) trxB::kan pAR5615 (ApR)N o v a g e n ,  U S A
Origami 
(DE3)
F- ompT hsdSB rB- mB-) gal dcm lacY1 ahpC gor522::Tn10 (TcR) trxB::kan pAR5615 (ApR) λ(DE3[lacI lacUV5-
T7 gene 1 ind1 sam7 nin5])
Novagen, USA
Plasmids
pGEX-4T1 AmpR, tac promoter, GST.TagG E  H e a l t h C a r e ,  U S A
pFO4 AmpR, T7lac promoter, His.Tag This StudyGroisillier et al. Microbial Cell Factories 2010, 9:45
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two different expression vectors and iii) the soluble
expression of the targeted proteins. Table 1 shows the
MARINE-EXPRESS consortium partners and the main
organisms studied. Moreover, we have analyzed target
genes from a lemon-shaped Virus-like Particle (PAV1)
isolated from the hyperthermophilic euryachaeote Pyro-
coccus abyssi [28] and some target genes from the brown
alga Laminaria digitata and the red alga Chondrus cris-
pus [6,7]. To enhance protein solubility and to facilitate
affinity chromatography in the next purification steps, we
used a gene fusion approach. Several tags have been
developed commercially to facilitate rapid single-step
purification [29,30]. The most popular are glutathion-S-
transferase (GST) [31] and polyhistidine (His6) [32] tags.
The His6-tag is popular because of its small size. GST
fusions help in obtaining soluble products of the whole
fusion protein simply by its presence. Each expression
scenario requires a specific vector. Re-cloning genes into
each of these vectors is extremely labor-intensive.
Recombinatorial cloning methods provide an opportu-
nity to minimize the effort required for alternate expres-
sion [33]. The present study includes two expression
vectors with either a His-tag (pFO4) or GST-tag (pGEX-
4T-1) at the N-terminal that allow the same restriction-
enzyme-based cloning in BamHI/EcoRI. Figure 1 shows
an average cloning success superior to 80%. This success
rate is clearly higher than those obtained with different
organisms [34] or at different centers from the Protein
Structure Initiative [13]. The use of auto-induction media
for small-scale protein production was successful. This is
measured by the high level of target protein expression
(>80%) that has been achieved.
The next stage, analysis of protein expression can be
carried out without affinity purification using SDS-PAGE
analysis which is a very reliable method, but not very sen-
sitive. Indeed, for direct detection of the His-tagged
product in the soluble fraction, a dot-blot procedure with
an anti-His antibody is often applied [35-37]. Dot-blot is a
fast method to screen expression and solubility of recom-
binant proteins using a convenient 96-well format. How-
ever, the reliability of this method is limited due to lack of
specificity of the detection method, and it does not give
information about the size and the purity of detected pro-
tein. One solution is to couple dot-blot with techniques
providing information about the actual size such as capil-
lary electrophoresis, SDS-PAGE or Western blotting. In
out study, the use of affinity mini-columns increased the
percentage of detected soluble targets by 15% for His-
tagged and 60% for GST-tagged targets. Moreover, this
method permitted to the expression level of recombinant
proteins to be estimated more precisely and confirmed
their correct molecular weight. In fact, the number of
obtained soluble proteins is generally under evaluated.
I n d e e d ,  w e  h a v e  s e e n  t h a t  f o r  s o m e  t a r g e t s  t h a t  w e r e
judged negative in small-scale experiments, culturing
them in a larger volume of auto-inducible medium, such
as 50 ml, in some cases allowed soluble expression of
these 'negatively' judged targets (data not shown). The tri-
age based on the small-scale results reduces the number
of targets that progress to large-scale culture preparation
[32], but in rare particular cases misses potential soluble
expression.
Previous studies have indicated that approximately 50%
of full-length proteins from the Eubacteria or Archaea
and only 10-20% of proteins from Eucarya  can be
expressed in E. coli in soluble form [38,39]. This percent-
age has been significantly increased (nearly 50%) for
human targets proteins using a multi-construct approach
[40]. In the present study, 44% of soluble proteins were
obtained. The best results are obtained for marine bacte-
ria with 67% of soluble proteins, then archaea with 45%
and as expected, Eucarya  give the smallest percentage
with 31%. These differences decrease if we take both
insoluble and soluble proteins into account (Figure 6). In
summary, we used a parallel production approach for
bacterial expression in medium throughput to yield 84
soluble proteins from a total of 192 marine targets (44%).
While expression or crystallization strategies can be
generalized to a common factor like their marine bacte-
rial or eukaryotic origin, the setup for the functional
screening is intimately bound to the gene family of inter-
est to the different consortium members (Table 1). This
latter step, performing the functional/biochemical char-
acterization of the soluble expressed proteins, will there-
fore be conducted by each partner and will focus on the
family of genes of their interest.
In conclusion, the present project provided purified
proteins that are key reagents for numerous assays that
address fundamental questions about their structure,
function and regulation. For the first time, our medium
throughput project allowed the expression of various pro-
teins of marine origin in parallel, independent of organ-
ism. A rapid and cost-effective small-scale screening
method for soluble expression of proteins from marine
organisms in E. coli has been established, allowing the
different partners to access large quantities of purified
protein and to choose among targets of their interest for
subsequent functional and/or structural analysis, which is
currently underway.
Methods
Strains, plasmids and culture conditions
The sources and relevant genotypes of the bacterial
strains as well as of the plasmids used are listed in Table 3.
Plasmid pGEX-4T-1 (GE Healthcare Life Science, USA) is
used to express protein in fusion with a glutathione-S-
transferase (GST) at the N-terminal. Plasmid pFO4 (a
vector modified from pET15b (Novagen, USA) to beGroisillier et al. Microbial Cell Factories 2010, 9:45
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compatible with the BamHI/EcoRI ligation strategy) gen-
erates a hexa-histidine tail at the N-terminal of recombi-
nant protein. Escherichia coli DH5α, used for standard
cloning procedures, and E. coli strains used for gene
expression experiments, were grown in Luria-Bertani
(LB) liquid or on LB solid medium, as described by Sam-
brook et al. in 1989 [41]. For expression tests, an auto-
inducible ZYP5052 medium [19] was used. All media
were supplemented, when necessary, with 100 μg ml-1
ampicillin (sodium salt).
Bioinformatics analysis of the target sequences
The potential signal peptides and transmembrane
domains have been predicted using SignalP and
TMHMM, respectively [15,16]. The modularity of each
target protein has been examined using Blast queries
against UniProt database, as well as domain searches with
the InterPro server [17]. The precise delineation of each
module has been refined using Hydrophobic Cluster
Analysis (HCA) [18]. For this study, 192 modules were
chosen with predicted masses between 7 and 140 kDa
and rearrayed into two 96-well plates. All procedures
were performed where possible in this 96-well format.
Primers design and cloning method
Expression vectors (pGEX-4T1 and pFO4) were digested
by  BamHI and EcoRI. For each target sequence, we
sought the restriction site recognized by BamHI, EcoRI or
their isocaudomers (respectively BglII and MfeI) using
BioEdit Sequence Alignment Editor (Ibis Biosciences
Inc., USA). The target genes were classified into four
compatible cloning strategies (BamHI/EcoRI,  BamHI/
MfeI, BglII/EcoRI and BglII/MfeI) in order to design the
correct oligonucleotide primers, and assign targets in 96-
wells plate). The standard scheme for primer design was
defined as: for the forward primers, 5'-[hexa-G  tail]-
[BamHI or BglII]-[Hybridization site]-3' and for the
reverse primers, 5'-[hexa-C  tail]-[EcoRI or MfeI]-[stop
anticodon]-[Hybridization site]-3'. Oligonucleotides for
PCR were purchased in 96-well plates from Operon Bio-
technologies GmbH (Cologne, Germany). PCR amplifica-
tion was performed on a GeneAmpR PCR System 2700
(Applied Biosystems, USA). The thermocycle utilized
was: denaturation at 95°C for 5 min and thirty cycles of
denaturing at 95°C for 30 s, annealing at 50°C for 30 s and
polymerization at 72°C for 4 min. Template amplification
was performed with Pfu polymerase (PROMEGA, USA)
and used with the conditions recommended by the sup-
plier. PCR reactions were analyzed on 1% agarose gels
using standard procedures [41]. The resulting PCR prod-
ucts were purified using the QIAquick™ 96 PCR purifica-
tion Kit (QIAGEN, USA), digested with appropriate
restrictions enzymes and cloned in parallel into the pFO4
and pGEX-4T1 expression vectors using standard proce-
dures [41]. PCR-screening was performed directly on the
DH5α bacterial colonies to verify clones with inserts on
expected size, using PCR primers which annealed
upstream and downstream of the insertion site of pGEX-
4T1 and pFO4. Target fragments were amplified using 10
μl of PCR Master Mix (PROMEGA, USA) added to 0.2 μl
of each primer (100 μM) with the same program
described above. Plasmid extraction was performed using
MiniPrep SV purification Kit (PROMEGA, USA) and
recombinant plasmids were used to transform E. coli
expression strains.
Screening for protein expression using 2 ml cultures
E. coli clones, for which the presence of the expression
gene had been verified by colony PCR as described previ-
ously, were tested for the expression of the desired pro-
tein. Screening was done using 2 ml cultures in 24-deep
well plates. Cultivation was performed in two phases.
First, transformed colonies were grown at 37°C overnight
in LB medium containing 100 μg ml-1 ampicillin. Then,
cultures were diluted 1:100 with auto-inductible
ZYP5052 medium [19] containing 100 μg ml-1 ampicillin
and subjected to further incubation at 20°C until the
desired density.
Lysis of cells and detection of proteins
For solubility assay, cell pellets from small-scale expres-
sion cultures were resuspended in 500 μl of lysis buffer
(Tris-HCl 50 mM, pH 7.5; NaCl 250 mM; EDTA 1 mM;
lysosyme 1 mg ml-1 ; DNAse 0.1 mg ml-1) and incubated
at 18°C for 1 hour and the soluble and insoluble fractions
separated by centrifugation (12000 g, 20 min, 4°C). Insol-
uble pellets were resuspended in 200 μl of lysis buffer
supplemented with urea 6 M. Samples from soluble and
insoluble fractions were separated by 12% sodium dode-
cyl-sulfate polyacrylamide gel electrophoresis (SDS-
PAGE) using 12% Criterion precast Bis-Tris gels with 26
wells. Targets were scored as positive for expression and
solubility if a detectable fusion protein of the correct
molecular weight was observed after Coomassie-staining.
In parallel, soluble fractions were purified using His or
GST Microspin columns (GE Healthcare Life Science,
USA) according to the protocol recommended by the
s u p p l i e r .  T h e  r e s u l t s  w e r e  a l s o  a n a l y z e d  b y  1 2 %  S D S -
PAGE.
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